Guideline-Based Strategies for the Management of Cardiovascular-Renal-Metabolic Conditions: Focus on Chronic Kidney Disease

Listen

0:00 / 0:00

This clinical brief is supported by Boehringer Ingelheim.

This clinical brief will explore the prevalence, clinical and economic burden, and management of cardiovascular-renal-metabolic (CRM) conditions while also identifying key areas of unmet need.

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

Guideline-Based Strategies for the Management of Cardiovascular-Renal-Metabolic Conditions: Focus on Chronic Kidney Disease

Newsletter

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

How Do GLP-1 Agonists Fit Into Stroke Care?

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD

Understanding Real-World MRI Utilization for ED Dizziness: Ava L. Liberman, MD

Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making